This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

CTI BioPharma Dividends and Buybacks

Dividend criteria checks 0/6

CTI BioPharma does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-5.3%

Buyback Yield

Total Shareholder Yield-5.3%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

CTI BioPharma: Reiterating Target Price Of $17 After Successful VONJO Launch

Aug 17

CTI BioPharma GAAP EPS of -$0.21 misses by $0.01, revenue of $12.33M beats by $3.23M

Aug 08

CTI BioPharma: Approval Is Great, Now There's The Follow Through

Jul 19

CTI BioPharma initiated at outperform at Cowen on potential for Vonjo for myelofibrosis

Jul 07

CTI BioPharma - 3.2x Potential Upside On A De-Risked Asset

May 04

CTI BioPharma Corp.: Pacritinib Approval, Downgrade To A Sell Rating

Apr 11

CTI BioPharma: A Speculative Buy Into The PDUFA Date

Mar 01

CTI BioPharma: Long And Troubled History, Finally Approaching Approval

Dec 24

FDA grants 'priority review' status to CTI Biopharma's pacritinib NDA

Jun 01

CTI BioPharma initiated buy at Stifel; cites potential in myelofibrosis

May 06

CTI BioPharma: Accelerated Approval Pathway Looks Attractive

Dec 06

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CTIC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CTIC's dividend payments have been increasing.


Dividend Yield vs Market

CTI BioPharma Dividend Yield vs Market
How does CTIC dividend yield compare to the market?
SegmentDividend Yield
Company (CTIC)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.2%
Industry Average (Biotechs)2.3%
Analyst forecast (CTIC) (up to 3 years)n/a

Notable Dividend: Unable to evaluate CTIC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CTIC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CTIC has not reported any payouts.


Discover strong dividend paying companies